48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial.

From:
Department for International Development
Published
1 January 2005
Country:
Uganda, Zimbabwe
Document Type:
Research Paper
Theme:
Health
Authors:
Kaleebu, P.

Citation

3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005: Abstract 3564.

48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial.

Updates to this page

Published 1 January 2005
Contents